Biochip

Acute coronary syndrome (ACS) refers to a range of acute myocardial states, ranging from unstable angina pectoris to acute myocardial infarction (AMI) with or without ST-segment elevation. Diagnosis and risk stratification (from low risk to high risk) are closely linked in ACS.

Biochemical markers in serum are used as analytical tools for the diagnosis in conjunction with physical examination, clinical history, electrocardiogram and imaging investigations. The Randox Cardiac Array enables the simultaneous determination of four cardiac markers (including late and early markers) from a single sample thus increasing the test result output to facilitate early detection , diagnosis and therapeutic monitoring.